Literature DB >> 10222431

Development of a new mouse brain tumor model using implantable micro-cannulas.

W Griffitt1, R P Glick, T Lichtor, D E Haughton, E P Cohen.   

Abstract

The objective of this study was to develop a brain tumor model in a mouse where gene therapy could be delivered either directly into a pre-established tumor bed or prophylacticly prior to tumor delivery (protective treatment). Micro-cannulas were constructed from metal tubing, implanted into the right frontal lobe of mice, and then secured in place in the skull with cement. Experiments evaluating the usefulness, reproducibility and morbidity of the system were performed. It was found that tumor cells could reproducibly be delivered into the right frontal lobe of the mice. Two tumors could be precisely delivered into the same area following injections at different times. Repeat injections were performed without a stereotaxic frame and without the need for repeat intracerebral needle tracts. There were no noticeable side effects of maintaining the cannulas in place for long periods of time. In summary, this system is useful for studying the effects of various treatment strategies on established brain tumors in a mouse model which more closely simulates the clinical situation. It obviates the need for time consuming stereotaxic procedures or repeat invasive intracerebral injections.

Entities:  

Mesh:

Year:  1999        PMID: 10222431     DOI: 10.1023/a:1006115221761

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  5 in total

1.  An examination of the central sites of action of cannabinoid-induced antinociception in the rat.

Authors:  W J Martin; S L Patrick; P O Coffin; K Tsou; J M Walker
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

2.  Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.

Authors:  M C Sañudo-Peña; S L Patrick; R L Patrick; J M Walker
Journal:  Neurosci Lett       Date:  1996-03-08       Impact factor: 3.046

3.  Treatment of glioma by engineered interleukin 4-secreting cells.

Authors:  J S Yu; M X Wei; E A Chiocca; R L Martuza; R I Tepper
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

4.  RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.

Authors:  J Tjuvajev; B Gansbacher; R Desai; B Beattie; M Kaplitt; C Matei; J Koutcher; E Gilboa; R Blasberg
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

5.  Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells.

Authors:  T Lichtor; R P Glick; T S Kim; R Hand; E P Cohen
Journal:  J Neurosurg       Date:  1995-12       Impact factor: 5.115

  5 in total
  3 in total

1.  A novel brainstem tumor model: functional and histopathological characterization.

Authors:  George I Jallo; Andrey Volkov; Cyrus Wong; Benjamin S Carson; Margaret B Penno
Journal:  Childs Nerv Syst       Date:  2006-10-05       Impact factor: 1.475

2.  Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in mice.

Authors:  Terry Lichtor; Roberta P Glick; Henry Lin; Amla Chopra; Insug O-Sullivan; Edward P Cohen
Journal:  Cancer Ther       Date:  2006

3.  Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors.

Authors:  Roberta P Glick; Terry Lichtor; Ripul Panchal; Anjuli Mahendra; Edward P Cohen
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.